MTOR and ovarian carcinoma: Interestingly, a recent study reported that PI3K/AKT/mTOR/NFκB axis is activated by ghrelin, an endogenous ligand for growth hormone secretagogue receptor (GHSR), promoting ovarian cancer cell survival and cisplatin resistance [57].